Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

In the past 5 yrs, positron emission tomography (PET), usually used with 18 F‐fluoro‐2‐
deoxy-glucose (FDG), has become an important imaging modality in lung cancer patients …

Lung cancer is the leading cause of cancer-related death in industrialized countries. The
overall mortality rate for lung cancer is high, and early diagnosis provides the best chance …

In the past 5 yrs, positron emission tomography (PET) with 18F-fluoro-2-deoxy-d-glucose
(FDG) has become an important imaging modality in lung cancer patients. At this time, the …

The availability of clinical positron emission tomography (PET) is increasing rapidly in the
developed world (1). This article reviews the role of PET scanning in lung cancer …

In the past 10 years, positron emission tomography (PET), usually with 18 F-fluoro-2-deoxy-
D-glucose (FDG), has become an important imaging modality in patients with lung cancer …

Lung cancer is the cause of 32% of all male cancer deaths and 25% of all female cancer
deaths. Because the prognosis depends on early diagnosis and staging, continuous …

In the past 5 years, metabolic imaging with positron emission tomography (PET) using 18F-
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …

Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Tumour stage is the strongest prognostic factor and the most …

Lung cancer has graduated from merely a reportable disease of 1912 to being the most
common cause of cancer death in developed countries in recent years. The annual number …